Norrby Erling, Uhnoo Ingrid, Brytting Mia, Zakikhany Katherina, Lepp Tiia, Olin Patrick
Kungl Vetenskapsakademien Centrum for vetenskapshistoria - Stockholm, Sweden Kungl Vetenskapsakademien Centrum for vetenskapshistoria - Stockholm, Sweden.
Enheten för vaccinationsprogram, Folkhälsomyndigheten, Solna - Solna, Sweden Enheten för vaccinationsprogram, Folkhälsomyndigheten, Solna - Solna, Sweden.
Lakartidningen. 2017 Sep 19;114:EPDT.
Polio close to eradication The WHO Global Polio Eradication Initiative has been highly successful. With a dramatic decrease in polio since it started in 1988, the number of globally reported cases reached a record low of 37 in 2016. This article describes the WHO Endgame Strategic Plan including milestones that have been reached and challenges that have to be overcome in order to reach the goal of polio eradication by 2020. Efforts to strengthen immunizations systems and to detect and interrupt polio virus transmission focus on the three remaining endemic countries, namely Pakistan, Afghanistan and Nigeria. In 2016 the WHO took the first step to withdraw the oral polio vaccine (OPV) by globally shifting from trivalent to bivalent OPV. The role of the inactivated vaccine (IPV) in the final phase of eradication and in the post-eradication situation is also considered. Certification of eradication and containment of all polio virus by the end of 2020 is a key objective. Legacy planning includes mainstreaming polio functions into ongoing public health programmes.
脊髓灰质炎接近根除 世界卫生组织全球根除脊髓灰质炎行动取得了巨大成功。自1988年启动以来,脊髓灰质炎病例急剧减少,2016年全球报告病例数降至创纪录的37例。本文介绍了世界卫生组织的终局战略计划,包括已达成的里程碑以及为在2020年实现根除脊髓灰质炎目标而必须克服的挑战。加强免疫接种系统以及检测和阻断脊髓灰质炎病毒传播的工作重点放在三个仍有脊髓灰质炎流行的国家,即巴基斯坦、阿富汗和尼日利亚。2016年,世界卫生组织迈出了全球停用三价口服脊髓灰质炎疫苗(OPV)、改用二价OPV的第一步。还考虑了灭活疫苗(IPV)在根除行动最后阶段以及根除后情况中的作用。2020年底实现根除认证并遏制所有脊髓灰质炎病毒是一个关键目标。遗留规划包括将脊髓灰质炎职能纳入正在进行的公共卫生项目的主流。